SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-044514
Filing Date
2024-04-16
Accepted
2024-04-15 17:33:44
Documents
5
Period of Report
2024-04-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A 2024_annual_meeting_def_.htm DEF 14A 784462
2 GRAPHIC img157472031_0.jpg GRAPHIC 17269
3 GRAPHIC img157472031_1.jpg GRAPHIC 17269
4 GRAPHIC img157472031_2.jpg GRAPHIC 267970
5 GRAPHIC img157472031_3.jpg GRAPHIC 286587
  Complete submission text file 0000950170-24-044514.txt   1597103
Mailing Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122
Business Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 650-800-3717
REVELATION BIOSCIENCES, INC. (Filer) CIK: 0001810560 (see all company filings)

IRS No.: 843898466 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39603 | Film No.: 24845636
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)